Brings total awards from BARDA to $110 million for development of broad SARS-CoV-2 and Influenza multispecifics, with potential funding of...
Sabin Vaccine Institute delivered 700 doses of its Marburg vaccine to Rwanda on Oct. 5, 2024. WASHINGTON, Oct. 05, 2024...
NORTHAMPTON, MA / ACCESSWIRE / October 4, 2024 / Episode 1 of Career On Purpose, a new podcast series from...
Now available for licensing, Ultra Soft Nasal Pump Spray leverages innovative spray nozzle chip technology for superior nasal cavity coverage...
PRINCETON, NJ, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the “Company” or “Sonnet”) (NASDAQ: SONN), a clinical-stage...
Business Activity Index at 59.9%; New Orders Index at 59.4%; Employment Index at 48.1%; Supplier Deliveries Index at 52.1% TEMPE,...
Coach integrates seamlessly into health plan care managers' workflow, enabling them to deliver tailored health education and coaching to members...
Advarra's Gene Therapy Ready (GTR) global site network expands to better support and accelerate the rapidly growing number of CGT...
Improved precision of the AI-Immunology™ platform in predicting clinically relevant vaccine targets boosts the potential of its AI-derived vaccine candidates...
AWS, Deloitte, Microsoft and NVIDIA bring the latest in AI technology, coordination, and compute to the alliance and back with...
Advancing CEPI's 100 Days Mission to Accelerate Vaccine Development DUSSELDORF, Germany, Oct. 2, 2024 /PRNewswire/ -- LenioBio, the leader in rapid...
Hussain brings more than 35 years of commercial leadership and operating experience in healthcare, most recently serving as CEO of...
HUNTSVILLE, AL, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its...
100% 36-month overall survival (OS) and progression-free survival (PFS) rates in patients fully treated with Versamune® HPV combined with chemoradiation (N=8)88%...
GAITHERSBURG, Md., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it entered into a...
NIAID will be conducting and sponsoring clinical trials to accelerate and to streamline the rapid development of next-generation COVID-19 vaccinesABINGDON,...
MALVERN, Pa., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused...
NEW YORK, Oct. 1, 2024 /PRNewswire/ -- Report on how AI is driving market transformation- The global transmission electron microscope market...
Burlington, Ontario--(Newsfile Corp. - October 1, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today...
- Phase 1 clinical trial for smoking cessation expected to dose first patient in 4Q 2024 - - The study...